MetaCap

Cytokinetics (CYTK) vs Rhythm Pharmaceuticals (RYTM)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Rhythm Pharmaceuticals (RYTM) has outperformed Cytokinetics (CYTK) over the past year, gaining 10.4% versus a loss of 22.4%. Over five years, RYTM leads with a +1116.0% price change compared with +30.1% for CYTK. Rhythm Pharmaceuticals is the larger company by market cap ($7.79 billion vs $7.07 billion), about 1.1 times the size, while Cytokinetics is growing revenue faster (+376.6% vs +45.8%).

Rhythm Pharmaceuticals converts more of its revenue into profit, with a net margin of -103.6% versus -891.6%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CYTK-22.40%RYTM+10.44%
+36%+4%-28%
Nov 21, 20251 yearNov 20, 2026
CYTK+24.28%RYTM+990.87%
+1077%+477%-123%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CYTK versus RYTM key metrics
MetricCYTKRYTM
Share price$50.78$112.36
Market cap$7.07B$7.79B
1-day change-1.32%-3.80%
YTD return-20.08%+4.97%
1-year return-22.40%+10.44%
5-year return+30.11%+1116.02%
EPS (TTM)$-6.02$-2.91
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$88.04M$189.76M
Revenue growth (YoY)+376.56%+45.83%
Net income (latest FY)$-784.96M$-196.54M
Gross margin—89.73%
Operating margin-695.44%-101.19%
Net margin-891.60%-103.57%
52-week high$88.31$122.20
52-week low$50.32$74.50
Distance from 52-week high-42.50%-8.05%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+115.48%+24.71%
Average volume2.02M1.10M
Shares outstanding139.30M69.33M
Employees673414
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • RYTM has outperformed CYTK by 32.8 percentage points over the past year.
  • Rhythm Pharmaceuticals is more profitable, keeping -103.6 cents of every revenue dollar as net income versus -891.6 cents for Cytokinetics.
  • Cytokinetics grew revenue faster in its latest fiscal year (+376.56% vs +45.83%).

About Cytokinetics

CYTK stock →

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM.

Health Care · Biotechnology: Pharmaceutical Preparations · 673 employees

About Rhythm Pharmaceuticals

RYTM stock →

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases in the United States and internationally. The company's lead product candidate is IMCIVREE (setmelanotide), a rare melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, Bardet-Biedl and Alström syndrome, Prader-Willi syndrome, and hypothalamic obesity.

Health Care · Biotechnology: Pharmaceutical Preparations · 414 employees

CYTK vs RYTM FAQ

Which is bigger, Cytokinetics or Rhythm Pharmaceuticals?

Rhythm Pharmaceuticals (RYTM) is larger, with a market capitalization of $7.79B compared with $7.07B for Cytokinetics (CYTK).

Which stock has performed better over the past year, CYTK or RYTM?

RYTM returned +10.44% over the past 12 months, compared with -22.40% for CYTK (price return, excluding dividends). Past performance does not predict future results.

Are Cytokinetics and Rhythm Pharmaceuticals in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons